Bilio-pancreatic Tumor, Obstructive Jaundice
Conditions
Brief summary
To assess the size of the common bile duct in a large cohort of patients with jaundice following a malignant tumor of the head of the pancreas or the distal bile duct receiving a diagnostic EA for biopsy and / or for evaluation of tissue resectability.
Interventions
PROCEDUREUltrasound endoscopy
After identification of the lesion, the common bile duct will be identified and followed by the point of dilation due to the compression of the known lesion up to the hilum of the liver
Sponsors
GCS Ramsay Santé pour l'Enseignement et la Recherche
European Clinical Trial Experts Network
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients with jaundice and an injury to the head of the pancreas recommended for EUS-guided tissue acquisition or staging * Patients with jaundice and distal CBD lesion suggestive of cholangiocarcinoma or Vater's ampulla carcinoma recommended for EUS-guided tissue acquisition or staging * Serum bilirubin level ≥ 3 mg / dl * Age ≥ 18 years old * Subject affiliated or beneficiary of a social security scheme. * Subject having been informed of this study and having given his no objection
Exclusion criteria
* Presence of altered anatomy due to previous gastric surgery (Billroth II or Roux-en-Y anastomosis) * Sphincterotomy performed previously, plastic biliary stent or metal stent placement * Percutaneous drainage of the bile ducts performed previously * Pregnant, breastfeeding or parturient woman * Protected patients: Adults under guardianship, curatorship or other legal protection, deprived of their liberty by judicial or administrative decision; hospitalized without consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of the common bile duct size | 1 day |
Countries
France
Outcome results
None listed